Virgin Money UK PLC ORD GBP0.10/ GB00BD6GN030 /
20/05/2024 17:35:20 | Diferencia -0.8000 | Volumen | Bid18:30:00 | Ask18:30:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
213.8000GBX | -0.37% | 1.94 millones Volumen de negocios(GBP): 4.13 millones |
213.6000Volumen de oferta: 50,000 | 214.2000Tamaño/ Volumen/ Formato de Ask: 25,000 | 2.88 mil millonesGBP | - | - |
GlobeNewswire
1:11
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Be...
Newsfile Corp
1:04
SEC Issues Exemptive Order Providing Additional Time for Certain Registrants to File Quarterly Repor...
GlobeNewswire
0:53
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Imp...
GlobeNewswire
0:15
Notre Dame de Namur University Announces the Appointment of Tseh-sien Kelly Vaughn, Ph.D. as Interim...
GlobeNewswire
0:05
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Cou...
GlobeNewswire
0:00
Targa Resources Corp. to Participate in 21st Annual Energy Infrastructure CEO & Investor Conference
GlobeNewswire
0:00
High Wire Reports Q1 2024 Revenue of $7.7 Million, up 57% Sequentially, Driving Adjusted EBITDA of $...
GlobeNewswire
20/05
ROSEN, THE FIRST FILING FIRM, Encourages Harbor Diversified, Inc. Investors to Secure Counsel Before...
GlobeNewswire
20/05
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock
GlobeNewswire
20/05
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Exscientia p.l.c Investors to Secure Counsel Before I...
GlobeNewswire
20/05
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
GlobeNewswire
20/05
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Globe Life Inc. f/k/a Torchmark Corporation In...
GlobeNewswire
20/05
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Teladoc Health ...
GlobeNewswire
20/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página